To date, studies investigating the impact of checkpoint inhibitors on MAIT cell functions are limited but targeting MAIT cells with checkpoint inhibitors may help harness their anti-tumour effector functions such as IFNγ and cytolytic molecule production. This evidence concerns the gene IFNG and neoplasm.